{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:46:23Z","timestamp":1792752383907,"version":"4.5.0"},"reference-count":44,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Thyroid nodules with indeterminate cytology often undergo diagnostic surgery despite a relatively low risk of malignancy, and molecular testing is limited by cost and availability. Because the Warburg effect is independent of cytological category, we evaluated intranodular lactate across all Bethesda categories, with emphasis on indeterminate cytology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective, cross-sectional study of 338 surgically treated thyroid nodules at a single tertiary referral center, with histopathology as the reference standard. Nodules were classified according to the Bethesda System and TI-RADS. Lactate was measured with a portable analyzer from the solid component of each nodule and from extranodular thyroid parenchyma, with capillary lactate as a systemic control. Performance was assessed using ROC analysis, sensitivity, specificity, likelihood ratios, and Bayesian post-test probabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Lactate increased progressively from extranodular parenchyma (1.85 \u00b1 0.49 mmol\/L) to benign (2.30 \u00b1 0.96) and malignant nodules (4.69 \u00b1 1.92 mmol\/L; P &amp;lt; 0.0001). The optimal cutoff was 3.0 mmol\/L (AUC: 0.90 overall; 0.83 in Bethesda III\u2013IV), with 91% sensitivity and 83% specificity. Negative predictive value was 92% for Bethesda I\/III\/IV\/V and 95.6% for Bethesda III\/IV. Lactate did not differ between classic and follicular papillary carcinoma subtypes (P = 0.34), and no extranodular sample affected by lymphocytic thyroiditis exceeded the cutoff. Estimated relative reduction in diagnostic surgery was 61.7% (Bethesda III\u2013IV) and 48.5% (Bethesda III\u2013V).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intranodular lactate is a feasible, low-cost metabolic biomarker that performs consistently across cytological categories, with greatest clinical value in Bethesda I, III, and IV nodules, where it may substantially reduce unnecessary diagnostic surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-26-0216","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:29:57Z","timestamp":1791390597000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["Intranodular lactate for thyroid nodule assessment: universal performance and maximum impact in indeterminate cytology"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-2023","authenticated-orcid":true,"given":"Luis-Mauricio","family":"Hurtado-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca-Estela","family":"Monroy-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Basurto-Kuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Pulido-Cejudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar-Rafael","family":"Montes-de-Oca-Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026102306361124200_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12902-020-0530-9","article-title":"Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology","volume":"20","author":"Yaprak Bayrak","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"2026102306361124200_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAP.0000000000000135","article-title":"Cytopathology of follicular cell nodules","volume":"24","author":"Rossi","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"2026102306361124200_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eprac.2024.05.016","article-title":"Thyroid nodules: past, present, and future","volume":"31","author":"Parsa","year":"2025","journal-title":"Endocr Pract"},{"key":"2026102306361124200_bib4","first-page":"1039","article-title":"The 2023 Bethesda system for reporting thyroid cytopathology","volume":"33","author":"Ali","year":"2023","journal-title":"Thyroid"},{"key":"2026102306361124200_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee","volume":"14","author":"Tessler","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"2026102306361124200_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40463-019-0338-7","article-title":"The role of repeat fine needle aspiration in managing indeterminate thyroid nodules","volume":"48","author":"Allen","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"2026102306361124200_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.20892\/j.issn.2095-3941.2018.0291","article-title":"BRAFV600E vs TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules","volume":"16","author":"Wu","year":"2019","journal-title":"Cancer Biol Med"},{"key":"2026102306361124200_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026102306361124200_bib9","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0067","article-title":"2023 European Thyroid Association Clinical Practice guidelines for thyroid nodule management","volume":"12","author":"Durante","year":"2023","journal-title":"Eur Thyroid J"},{"key":"2026102306361124200_bib10","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/jcm13061759","article-title":"Current state of molecular cytology in thyroid nodules: platforms and their diagnostic and theranostic utility","volume":"13","author":"Hannoush","year":"2024","journal-title":"J Clin Med"},{"key":"2026102306361124200_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2022.103394","article-title":"Diagnostic performance of the second-generation molecular tests in the assessment of indeterminate thyroid nodules: a systematic review and meta-analysis","volume":"43","author":"Lee","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"2026102306361124200_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/clinem\/dgac688","article-title":"Real-world performance of the Afirma genomic sequencing classifier (GSC)-A meta-analysis","volume":"108","author":"Nasr","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026102306361124200_bib13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/cancers17071156","article-title":"Impact of molecular testing on surgical decision-making in indeterminate thyroid nodules: a systematic review and meta-analysis of recent advancements","volume":"17","author":"Chowdhury","year":"2025","journal-title":"Cancers"},{"key":"2026102306361124200_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","article-title":"Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study","volume":"5","author":"Steward","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026102306361124200_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamasurg.2018.1153","article-title":"Performance of a genomic sequencing classifier for the preoperative diagnosis of cytologically indeterminate thyroid nodules","volume":"153","author":"Patel","year":"2018","journal-title":"JAMA Surg"},{"key":"2026102306361124200_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/thy.2018.0779","article-title":"Molecular testing versus diagnostic lobectomy in Bethesda III\/IV thyroid nodules: a cost-effectiveness analysis","volume":"29","author":"Nicholson","year":"2019","journal-title":"Thyroid"},{"key":"2026102306361124200_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.590128","article-title":"Thyroid nodule molecular testing: is it ready for prime time?","volume":"11","author":"Khan","year":"2020","journal-title":"Front Endocrinol"},{"key":"2026102306361124200_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211041243","article-title":"Contemporary perspectives on the Warburg effect inhibition in cancer therapy","volume":"28","author":"Kozal","year":"2021","journal-title":"Cancer Control"},{"key":"2026102306361124200_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14737159.2022.2065196","article-title":"Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer","volume":"22","author":"Nava","year":"2022","journal-title":"Expert Rev Mol Diagn"},{"key":"2026102306361124200_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710037","article-title":"Revisited metabolic control and reprogramming cancers by means of the Warburg effect in tumor cells","volume":"23","author":"Fukushi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026102306361124200_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J Physiol"},{"key":"2026102306361124200_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-34025-4_3","article-title":"Lactate and lactate transporters as key players in the maintenance of the Warburg effect","volume":"1219","author":"Pereira-Nunes","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"2026102306361124200_bib23","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.3390\/cancers14246028","article-title":"Revisiting the Warburg effect with focus on lactate","volume":"14","author":"Kocianova","year":"2022","journal-title":"Cancers"},{"key":"2026102306361124200_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2026102306361124200_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001899","article-title":"A method-comparison study regarding the validity and reliability of the lactate plus analyzer","volume":"3","author":"Hart","year":"2013","journal-title":"BMJ Open"},{"key":"2026102306361124200_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13049-018-0510-5","article-title":"Capillary and venous lactate measurements with a handheld device compared to venous blood-gas analysis for emergency patients","volume":"26","author":"Stoll","year":"2018","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2026102306361124200_bib27","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1007\/s00421-024-05572-6","article-title":"Precision and accuracy of four handheld blood lactate analyzers across low to high exercise intensities","volume":"124","author":"Mentzoni","year":"2024","journal-title":"Eur J Appl Physiol"},{"key":"2026102306361124200_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22885","article-title":"Comparison of point-of-care and central laboratory analyzers for blood gas and lactate measurements","volume":"33","author":"Indrasari","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"2026102306361124200_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2026102306361124200_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"2026102306361124200_bib32","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.2967\/jnumed.107.047258","article-title":"Causes and consequences of increased glucose metabolism of cancers","volume":"49","author":"Gillies","year":"2008","journal-title":"J Nucl Med"},{"key":"2026102306361124200_bib33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hed.26598","article-title":"Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules","volume":"43","author":"Todsen","year":"2021","journal-title":"Head Neck"},{"key":"2026102306361124200_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.649522","article-title":"Thyroseq v3, Afirma GSC, and microRNA panels versus previous molecular tests in the preoperative diagnosis of indeterminate thyroid nodules: a systematic review and meta-analysis","volume":"12","author":"Silaghi","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026102306361124200_bib35","first-page":"1144","article-title":"Assessing bias and limitations of clinical validation studies of molecular diagnostic tests for indeterminate thyroid nodules: systematic review and meta-analysis","volume":"32","author":"DiGennaro","year":"2022","journal-title":"Thyroid"},{"key":"2026102306361124200_bib36","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1530\/ERC-17-0405","article-title":"Genetic testing for indeterminate thyroid cytology: review and meta-analysis","volume":"25","author":"Vargas-Salas","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026102306361124200_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fonc.2018.00082","article-title":"Metabolic reprogramming in thyroid carcinoma","volume":"8","author":"Coelho","year":"2018","journal-title":"Front Oncol"},{"key":"2026102306361124200_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3803\/EnM.2020.819","article-title":"Lactate dehydrogenase a as a potential new biomarker for thyroid cancer","volume":"36","author":"Ban","year":"2021","journal-title":"Endocrinol Metab"},{"key":"2026102306361124200_bib39","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.acra.2024.04.033","article-title":"Lactate dehydrogenase A is associated with elevated FDG metabolism, radioiodine non-avidity, and poor prognosis in differentiated thyroid cancer","volume":"31","author":"Tian","year":"2024","journal-title":"Acad Radiol"},{"key":"2026102306361124200_bib29","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"2026102306361124200_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11154-023-09842-0","article-title":"Molecular testing for thyroid nodules: where are we now?","volume":"25","author":"Ferraz","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"2026102306361124200_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.surg.2021.04.050","article-title":"Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules","volume":"171","author":"Hu","year":"2022","journal-title":"Surgery"},{"key":"2026102306361124200_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOO.0000000000000698","article-title":"Molecular analysis of fine-needle aspiration cytology in thyroid disease: where are we?","volume":"29","author":"Grani","year":"2021","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"2026102306361124200_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40463-022-00604-7","article-title":"Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules","volume":"51","author":"Dharampal","year":"2022","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"2026102306361124200_bib44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM197810262991705","article-title":"Problems of spectrum and bias in evaluating the efficacy of diagnostic tests","volume":"299","author":"Ransohoff","year":"1978","journal-title":"N Engl J Med"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0216\/526262\/etj-26-0216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-26-0216\/526262\/etj-26-0216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:36:24Z","timestamp":1792751784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/5\/ETJ260216\/78337\/Intranodular-lactate-for-thyroid-nodule-assessment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-26-0216","relation":{},"ISSN":["2235-0802"],"issn-type":[{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"ETJ260216"}}